How Parkinson’s Disease Affects Daily Life and Mobility

Introduction

Parkinson’s is more than slowed movement- it significantly influences one’s daily life quality.

Parkinson’s disease (PD) accounts for a progressive neurological disorder that majorly affects an individual’s movement. Globally, more than 8.5 million individuals were affected with PD in 2019, among whom 5.8 million experienced disability adjusted life years (DALYs) [1]. Initially, the symptoms appear as tremors, slow movement and stiffness. The brain cells producing dopamine get compromised. Parkinson’s Disease (PD) cure is complex, with early diagnosis and opting for an appropriate treatment regime, its management is possible. 

Ask The Expert

What Is Parkinson’s Disease?

Parkinson’s affects dopaminergic (dopamine-producing) neurons in the substantia nigra region of the brain. The condition worsens with time. Dopamine is responsible for controlling movement. 

Dopamine acts as a neurotransmitter present in the brain in the nigrostriatal pathways that control movement in the body. At later stages, 60-80% of the neurons are lost, which leads to a significant dopamine shortage. Dopamine controls ‘go’ and ‘stop’ signals in the basal ganglia in the brain. The dopamine depletion disrupts smooth muscle movement. This leads to bradykinesis (slow movement), rigidity, stiffness, tremors, and postural instability. 

What are Parkinson’s Disease Types & Causes?

Parkinson’s Disease causes are divided into two major subtypes:

• Idiopathic PD: It is the most common type of PD, and the exact cause is unknown. Researchers unveiled alpha-synuclein protein in the brain does not fold correctly. The clumps formed are called ‘Lewy bodies’ that build up in the brain and damage dopaminergic neurons.
• Familial PD: Genetic cause of PD, runs in the family. The individuals affected can be at a younger age.

The major cause of PD involves a significant drop in dopamine levels. The condition affects an individual’s mood, movement, thinking ability, or memory. The exact cause is yet unknown, yet the risk factors play a crucial role in the development of the condition. This includes: 

• Age: In many individuals, PD develops with age (approximately 60 years)
• Gender: PD majorly affects males
• Hereditary: Runs in families
• Environmental Condition: Exposure to environmental toxins like pesticides, long-term metal exposure like manganese, etc.

What are Parkinson’s Disease Symptoms? 

PD signs and symptoms involve both motor and non-motor signs.

Motor Symptoms Include:

• Bradykinesia or hypokinesia (slow or paucity in movement)
• Resting tremor in hands or feet
• Rigidity or stiffness in the limb
• Postural instability involving gait or balance issues
• Increased risk of falls or disorientation 

Non-Motor Symptoms Include:

• Psychological issues (mood swings, anxiety, depression, hallucination, apathy)
• Insomnia or restlessness 
• Orthostatic hypotension
• Constipation, digestive problems, urinary urgency
• Sensory loss, such as smell
• Sexual dysfunction or drooling

How Parkinson’s Disease Impacts Daily Life?

The impact of PD on daily life activities is significant. This includes:

• Difficulty in performing routine activities, loss of independence
• Compromised ability to speech
• Trouble in swallowing, risk of choking (weakening of throat muscles)
• Uncontrolled facial Changes
• Unregulated emotions and compromised cognitive ability

How is Parkinson’s Disease Diagnosed? 

Doctors diagnose PD via medical examination and laboratory tests. The diagnostic test includes:

• Physical Examination: Hypomimia (lack of facial expression), reduced blinking (2-10/min), Monotonous speech
• Laboratory Examination: Blood Test, Biomarker identification (alpha-synuclein), genetic marker (SNCa, LRRK2), biomarker for axonal damage (NfL)
• Neurological Imaging: Brain imaging, MRIs, DaTscan (involves dopamine transporter scan)

*NOTE: Identification of early signs and diagnosis enables clinicians to develop personalized treatment for individuals. It allows better management and improved conditions

What are the Treatment Options?

Parkinson’s Disease Treatment intends to improve patients’ quality of life. The care regime involves a combination of palliative care, therapy, and supportive care. The treatment involves:

Palliative Care

• Carbidopa-Levodopa (transforms into dopamine in the brain) 
• Dopamine Agonists (acts as dopamine in the brain)
• MAO inhibitors (slows breakdown of dopamine in the brain)
• COMT inhibitor (extend action of levodopa)
• Amantadine (reduces involuntary movement)
• Anticholinergic (reduces tremors)
• Medication for co-morbid condition management (insomnia, anxiety, depression, sexual dysfunction)

Therapy

• Physical therapy (improve balance, walking, strength)
• Occupational Therapy (Improvement in daily life tasks)
• Speech Therapy (improvement in swallowing and speaking)

Neurosurgical Intervention

• Deep Brain Stimulation (DBS) involves electrode implantation into specific brain areas. They manage motor symptoms

Lifestyle Modification

• Nutritional intervention or dietary modification (regular intake of a balanced diet)
• Supplements to fulfill macronutrients and micronutrients
• Regular physical activities
• Maintain sleep cycle  
• Providing emotional and social support

Regenerative Approaches

• Stem cell therapy for PD for the regeneration of dopamine-producing neurons
• Mesenchymal stem cells (MSCs) induce paracrine effects (anti-inflammation, improved cell-to-cell communication, and repair mechanisms)
• Improvement in neural networking and neuroprotection
• The therapeutic implication is at an early stage. Preclinical and clinical evidence displayed the safety and tolerance of stem cell therapy.

*NOTE: The success of therapy widely depends on the quality of the stem cells. Advancells, India, is among the leading stem cell research-based laboratories that isolate and maintain superior quality stem cells.

What is the Latest Research on Parkinson’s Disease?

• Targeted Drug: Tavapadon, currently under FDA review. The molecule targets the PINK1 protein for mitochondrial protection [2]
• Amchepry (Laguneprocell): Japan approves first induced pluripotent stem cells (iPSCs) for Parkinson’s. iPSCs are guided to develop dopaminergic neuron progenitor cells, surgically introduced into brain regions. The goal was the replacement of lost or damaged nerve cells and the restoration of dopamine signaling [3]. The cells remained viable among all the patients. Improvement in the Motor Symptoms Diagnostic and Treatment Rating Scale was seen after 24 months of transplantation.

In the future, large-scale clinical trials need to be launched for establishing long-term safety, tolerance and efficacy of the treatment.

When to See a Doctor for Parkinson’s Disease?

• Dysregulated daily life activities (persistent tremors, stiffness or slowed movement)
• Unexplained change in balance or posture
• Non-motor symptoms like loss of smell, fatigue, insomnia, etc.
• Appearance of early signs and symptoms

Conclusion

Early symptom recognition and diagnosis are key to slowing functional decline among PD patients. The combination of palliative care, physical therapy, and lifestyle modification potentially manages the disease progression. Stem Cell Therapy is at an early stage of therapeutic application that potentially can be a long-term solution. Overall, proactive care, regular medical follow-ups and developing a supportive system are key in effective PD management. 

References

1. World Health Organization. Parkinson disease [Internet]. Geneva: World Health Organization; 2023 Aug 9. Available from: Parkinson disease fact sheet
2. The Michael J. Fox Foundation for Parkinson’s Research. New Parkinson’s drug tavapadon submitted for FDA review. 2025 Nov 6. Available from: https://www.michaeljfox.org/news/new-parkinsons-drug-tavapadon-submitted-fda-review
3. Lobo A. Japan grants conditional approval to Amchepry cell therapy for Parkinson’s. Parkinson’s News Today; 2026 Mar 10. Available from: https://parkinsonsnewstoday.com/news/japan-grants-conditional-approval-amchepry-parkinsons/

FAQ’s

Q. What is Parkinson’s Disease?

PD is a neurological condition that occurs due to damage to dopaminergic neurons in the brain. The common symptoms include tremors, stiffness, bradykinesis cognition decline, etc.  

Q. What are Parkinson’s Disease Early Symptoms?

The early symptoms include slight tremors, muscle stiffness, slow movements, fatigue, insomnia, loss of smell, etc. 

Q. What is Stem Cell Therapy for PD Patients?

Stem cell therapy involves a regenerative approach that intends to regenerate lost dopaminergic neurons. They create a supportive environment via neuroprotection, decreasing neuroinflammation, immunomodulation, and inducing repair mechanisms. The studies are still at an early stage, but they can potentially lay long-term solutions.

Q. What is the Syn-One Test for PD?

Syn-One Test® is a biopsy procedure that uses skin samples for the presence of synuclein in the nerves. The test identifies if the synuclein undergoes phosphorylation.  The test reflects the function of alpha-synuclein (a biomarker of PD).